OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Endocytosis in cancer and cancer therapy
Blerida Banushi, Shannon R. Joseph, Benedict Lum, et al.
Nature reviews. Cancer (2023) Vol. 23, Iss. 7, pp. 450-473
Closed Access | Times Cited: 94

Showing 1-25 of 94 citing articles:

Tunable Multivalent Aptamer-Based DNA Nanostructures To Regulate Multiheteroreceptor-Mediated Tumor Recognition
Xiaoxue Hu, Hongli Chi, Xiaoyi Fu, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 4, pp. 2514-2523
Closed Access | Times Cited: 21

Expanding the horizons of targeted protein degradation: A non-small molecule perspective
Xiaowei Huang, Fengbo Wu, Jing Ye, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 6, pp. 2402-2427
Open Access | Times Cited: 16

Receptor-ligand interactions for optimized endocytosis in targeted therapies
Yejin Sung, Young‐Jin Choi, Eun Sun Kim, et al.
Journal of Controlled Release (2025) Vol. 380, pp. 524-538
Open Access | Times Cited: 2

The Chemical Inhibitors of Endocytosis: From Mechanisms to Potential Clinical Applications
Olga Szewczyk‐Roszczenko, Piotr Roszczenko, Anna Shmakova, et al.
Cells (2023) Vol. 12, Iss. 18, pp. 2312-2312
Open Access | Times Cited: 23

Targeted protein degradation: advances in drug discovery and clinical practice
Guangcai Zhong, Xiaoyu Chang, Weilin Xie, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 13

The uptake of extracellular vesicles: research progress in cancer drug resistance and beyond
Luomeng Qian, Pangzhou Chen, Shiwu Zhang, et al.
Drug Resistance Updates (2025) Vol. 79, pp. 101209-101209
Closed Access | Times Cited: 1

Considerations for the design of antibody drug conjugates (ADCs) for clinical development: lessons learned
Alfonso López de Sá, Cristina Díaz‐Tejeiro, Elisa Poyatos‐Racionero, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 16

Alveolar-capillary endocytosis and trafficking in acute lung injury and acute respiratory distress syndrome
Vitalii Kryvenko, István Vadász
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6

The diverse dependence of galectin-1 and -8 on multivalency for the modulation of FGFR1 endocytosis
Dominika Żukowska, Aleksandra Chorążewska, Krzysztof Ciura, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6

Albumin is a reliable drug-delivering molecule: Highlighting points in cancer therapy
Akmal M. Asrorov, Nurkhodja Mukhamedov, Muzaffar Kayumov, et al.
Medicine in Drug Discovery (2024) Vol. 22, pp. 100186-100186
Open Access | Times Cited: 5

Macropinocytosis at the crossroad between nutrient scavenging and metabolism in cancer
Elena Rainero
Current Opinion in Cell Biology (2024) Vol. 88, pp. 102359-102359
Open Access | Times Cited: 5

Role of Exosomes in Cancer and Aptamer-Modified Exosomes as a Promising Platform for Cancer Targeted Therapy
Yating Wu, Yue Cao, Li Chen, et al.
Biological Procedures Online (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 5

Achieving Endo/Lysosomal Escape Using Smart Nanosystems for Efficient Cellular Delivery
Nimeet Desai, Dhwani Rana, Sagar Salave, et al.
Molecules (2024) Vol. 29, Iss. 13, pp. 3131-3131
Open Access | Times Cited: 5

A bioinspired doxorubicin-carried albumin Nanocage against aggressive Cancer via systemic targeting of tumor and lymph node metastasis
Haroon Iqbal, Anam Razzaq, Fan Liu, et al.
Journal of Controlled Release (2024) Vol. 372, pp. 829-845
Closed Access | Times Cited: 5

Metal Oxide Nanoparticles as Efficient Nanocarriers for Targeted Cancer Therapy: Addressing Chemotherapy-Induced Disabilities
Mohamed Taha Yassin, Fatimah Al-Otibi, Sarah A. Al-Sahli, et al.
Cancers (2024) Vol. 16, Iss. 24, pp. 4234-4234
Open Access | Times Cited: 5

Tanshinlactone triggers methuosis in breast cancer cells via NRF2 activation
Wanjun Lin, Zifeng Huang, Xuening Zhang, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access

Self-assembled HO-1i-Pt(IV) nanomedicine targeting p38/MAPK and MDR pathways for cancer chemo-immunotherapy
Xiaomeng Liu, Zhe Li, Xiaoya Wang, et al.
Journal of Controlled Release (2025) Vol. 379, pp. 797-813
Closed Access

Cathepsin B dependent Activatable Trigger Fluorophore (CAT-Fluor) for in situ functional imaging of antibody-drug conjugates
Jiangtao Ning, Yikai Shen, Hui Gao, et al.
Biosensors and Bioelectronics (2025), pp. 117184-117184
Closed Access

Diagnosis of the Skin Cancer by Vision Transformers
Uğur Demiroğlu
Düzce Üniversitesi Bilim ve Teknoloji Dergisi (2025) Vol. 13, Iss. 1, pp. 588-598
Open Access

Hierarchical DNA Octahedral Nanoplatform for in Situ Biosensing and Clinical Monitoring of Acute Lymphoblastic Leukemia
Qian Liu, Man Shen, Hanqing Xu, et al.
Advanced Healthcare Materials (2025)
Closed Access

Hydrophobic Chitosan Derivatives for Gene and Drug Delivery in Cancer Therapies
Daria N. Poshina, Anna D. Rakshina, Yury А. Skorik
Polysaccharides (2025) Vol. 6, Iss. 1, pp. 11-11
Open Access

Investigating the Expression Pattern, Prognostic and Immunological Significance of the WNT family in Breast Cancer
Fatema Tuj Johora Fariha, Muztaba Fuad, Chandan Saha, et al.
Research Square (Research Square) (2025)
Closed Access

Bio-nanocomplexes impair iron homeostasis to induce non-canonical ferroptosis in cancer cells
Xin Wang, Tianyi Zhang, Shuai Wang, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access

Page 1 - Next Page

Scroll to top